Unexplained Falls in the Elderly: Is It the Brain, Nerves, or Something Else?

A Comprehensive Review for Critical Care Practitioners

Dr Neeraj Manikath ,claude.ai

Abstract

Falls among the elderly represent a complex multifactorial syndrome requiring systematic neurological evaluation. This review examines the neurological underpinnings of unexplained falls, focusing on parkinsonism, normal pressure hydrocephalus, cerebellar ataxia, sensory neuropathy, orthostatic hypotension, and frontal lobe disease. We provide evidence-based diagnostic approaches and clinical pearls for critical care practitioners managing elderly patients with recurrent falls. Understanding these mechanisms is crucial for preventing fall-related morbidity and mortality in intensive care settings.

Keywords: Falls, elderly, parkinsonism, normal pressure hydrocephalus, cerebellar ataxia, orthostatic hypotension

Introduction

Falls affect approximately 30% of community-dwelling adults over 65 years annually, with the incidence rising to 50% in those over 80 years.¹ While many falls have obvious precipitants, unexplained falls present a diagnostic challenge requiring systematic neurological evaluation. The critical care physician must recognize that falls often represent the final common pathway of multiple underlying pathophysiological processes affecting the brain, peripheral nervous system, and cardiovascular system.

The etiology of unexplained falls extends beyond simple mechanical factors to encompass complex neurological conditions that compromise balance, cognition, and motor control. This review examines six key neurological entities that frequently contribute to falls in elderly patients: parkinsonism, normal pressure hydrocephalus, cerebellar ataxia, sensory neuropathy, orthostatic hypotension, and frontal lobe disease.

Parkinsonism: The Masked Culprit

Pathophysiology

Parkinsonism encompasses a spectrum of disorders characterized by bradykinesia, rigidity, tremor, and postural instability. While idiopathic Parkinson's disease represents the most common form, drug-induced parkinsonism, progressive supranuclear palsy, and multiple system atrophy frequently contribute to falls in elderly patients.² The disruption of dopaminergic pathways in the basal ganglia leads to impaired automatic postural responses and compromised balance recovery mechanisms.

Clinical Presentation

Early parkinsonism may present subtly with decreased arm swing, shuffling gait, or mild bradykinesia before classic tremor develops. Falls occur due to freezing episodes, particularly when turning or navigating doorways, and impaired protective reflexes during loss of balance.³

Clinical Pearl: The "pull test" assesses postural instability by standing behind the patient and giving a sudden backward pull on the shoulders. Inability to regain balance within two steps indicates significant postural instability and high fall risk.

Diagnostic Approach

The diagnosis relies primarily on clinical assessment using the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS). DaTscan imaging can differentiate degenerative from drug-induced parkinsonism when clinical uncertainty exists.⁴

Oyster Alert: Drug-induced parkinsonism from antipsychotics, antiemetics, or calcium channel blockers may be reversible but can take months to improve after discontinuation. Don't dismiss parkinsonian features in patients with recent medication changes.

Normal Pressure Hydrocephalus: The Great Mimicker

Pathophysiology

Normal pressure hydrocephalus (NPH) results from impaired cerebrospinal fluid absorption leading to ventricular enlargement despite normal or mildly elevated intracranial pressure. This condition affects approximately 1-2% of adults over 65 years and presents with the classic triad of gait disturbance, cognitive decline, and urinary incontinence.⁵

Clinical Presentation

The gait disturbance in NPH is characterized by a wide-based, shuffling pattern with difficulty initiating steps—often described as "magnetic gait" where feet appear stuck to the floor. Falls occur due to gait apraxia, where patients know what they want to do but cannot execute the motor program effectively.⁶

Clinical Pearl: The "tap test" involves removing 30-50 mL of cerebrospinal fluid via lumbar puncture and assessing gait improvement within 24-72 hours. Significant improvement suggests potential benefit from ventriculoperitoneal shunting.

Diagnostic Approach

Brain MRI reveals ventricular enlargement with an Evans index >0.3 (ratio of frontal horn width to biparietal diameter). Additional findings include periventricular white matter changes and corpus callosum thinning.⁷ Advanced imaging with MR cisternography or nuclear medicine CSF flow studies may provide additional diagnostic information.

Hack: The "DESH" sign (Disproportionately Enlarged Subarachnoid space Hydrocephalus) on MRI—enlarged Sylvian fissures with tight sulci at the high convexity—strongly suggests NPH and correlates with shunt responsiveness.

Cerebellar Ataxia: Beyond Coordination

Pathophysiology

Cerebellar dysfunction affects balance through impaired integration of sensory input, disrupted motor planning, and compromised error correction mechanisms. Causes include chronic alcohol use, medications (phenytoin, lithium), stroke, and neurodegenerative diseases.⁸

Clinical Presentation

Cerebellar ataxia manifests as wide-based gait, truncal instability, and difficulty with tandem walking. Falls occur due to inability to adjust posture dynamically and impaired protective responses when balance is challenged.

Clinical Pearl: The "heel-to-shin test" performed supine may be normal in pure cerebellar disease, while sitting unsupported or tandem walking reveals significant instability. This dissociation helps distinguish cerebellar from sensory ataxia.

Diagnostic Approach

Assessment includes finger-to-nose testing, rapid alternating movements, and gait evaluation. MRI may reveal cerebellar atrophy, while genetic testing should be considered for hereditary ataxias when family history is suggestive.⁹

Oyster Alert: Medication-induced cerebellar toxicity can develop insidiously with therapeutic drug levels. Monitor patients on phenytoin, carbamazepine, or lithium for subtle gait changes that may precede overt ataxia.

Sensory Neuropathy: The Silent Saboteur

Pathophysiology

Peripheral sensory neuropathy affects proprioception and vibration sense, leading to sensory ataxia and increased fall risk. Diabetic neuropathy represents the most common cause, though vitamin B12 deficiency, alcohol use, and inflammatory conditions contribute significantly.¹⁰

Clinical Presentation

Patients describe numbness, tingling, and feeling like walking on cotton or sand. Falls occur particularly in low-light conditions when visual compensation for proprioceptive loss is impaired. The classic "sensory ataxia" worsens with eye closure (positive Romberg sign).

Clinical Pearl: The "128 Hz tuning fork test" at the great toe provides a simple bedside assessment of large-fiber sensory function. Inability to perceive vibration correlates strongly with fall risk and diabetic foot complications.

Diagnostic Approach

Nerve conduction studies and electromyography confirm the diagnosis and characterize the pattern of involvement. Laboratory evaluation should include glucose, HbA1c, vitamin B12, folate, and thyroid function.¹¹

Hack: The "10-gram monofilament test" at standard foot locations provides quantitative assessment of protective sensation. Inability to detect the monofilament predicts high fall risk and requires aggressive foot protection strategies.

Orthostatic Hypotension: The Cardiovascular Culprit

Pathophysiology

Orthostatic hypotension (OH) affects 10-20% of elderly individuals and increases fall risk through cerebral hypoperfusion. Causes include volume depletion, medications, autonomic neuropathy, and age-related cardiovascular changes.¹²

Clinical Presentation

Classic symptoms include dizziness, lightheadedness, and syncope upon standing. However, many elderly patients experience falls without clear prodromal symptoms, particularly when OH is chronic and compensatory mechanisms are impaired.

Clinical Pearl: Measure blood pressure supine and after 1 and 3 minutes of standing. A drop of ≥20 mmHg systolic or ≥10 mmHg diastolic defines OH. Heart rate response helps distinguish neurogenic from non-neurogenic causes.

Diagnostic Approach

Comprehensive medication review identifies culprit drugs including antihypertensives, diuretics, antidepressants, and alpha-blockers. Autonomic function testing with tilt table or pharmacological challenges may be indicated for recurrent symptoms.¹³

Oyster Alert: Post-prandial hypotension occurs 30-75 minutes after meals and may be more pronounced than morning orthostatic changes. Consider timing of falls relative to meals when evaluating elderly patients.

Frontal Lobe Disease: The Executive Problem

Pathophysiology

Frontal lobe dysfunction affects executive function, attention, and motor planning, leading to impaired judgment and increased fall risk. Causes include normal aging, vascular dementia, frontotemporal dementia, and chronic traumatic encephalopathy.¹⁴

Clinical Presentation

Patients demonstrate poor judgment, disinhibition, and difficulty with complex motor tasks. Falls occur due to overconfidence in abilities, poor environmental awareness, and impaired risk assessment rather than primary motor dysfunction.

Clinical Pearl: The "go/no-go test" assesses frontal executive function by asking patients to tap once for one tap and not respond to two taps. Difficulty with this task correlates with fall risk and functional decline.

Diagnostic Approach

Neuropsychological testing reveals deficits in executive function, attention, and working memory. Brain MRI may show frontal atrophy or white matter changes, while FDG-PET can demonstrate hypometabolism in frontal regions.¹⁵

Hack: The "dual-task gait assessment" involves walking while performing a cognitive task (counting backwards by 7s). Significant gait deterioration during dual-tasking indicates frontal-subcortical dysfunction and high fall risk.

Integrated Diagnostic Approach

Clinical Assessment Framework

The evaluation of unexplained falls requires systematic assessment of multiple domains:

Medication Review: Identify fall-risk medications including benzodiazepines, anticholinergics, and cardiovascular drugs
Neurological Examination: Focus on gait, balance, reflexes, and cognitive function
Cardiovascular Assessment: Orthostatic vital signs and cardiac rhythm evaluation
Functional Assessment: Activities of daily living and mobility evaluation
Environmental Review: Home safety and fall hazards assessment

Clinical Pearl: The "timed up-and-go test" provides objective assessment of functional mobility. Time >14 seconds indicates high fall risk and need for intervention.

Diagnostic Algorithms

A structured approach should prioritize common and treatable causes:

Initial Assessment: History, physical examination, medication review
Basic Laboratory: Complete blood count, comprehensive metabolic panel, vitamin B12, TSH
Imaging: Brain MRI if cognitive changes or focal neurological signs
Specialized Testing: Based on clinical suspicion (DaTscan, lumbar puncture, nerve conduction studies)

Oyster Alert: Multiple pathologies often coexist in elderly patients. Don't stop the evaluation after identifying one cause—look for additional contributing factors that may be modifiable.

Critical Care Considerations

ICU-Specific Factors

Critical care environments present unique challenges for fall prevention:

Delirium: Affects 20-50% of ICU patients and significantly increases fall risk
Sedation: Residual effects of sedatives impair balance and judgment
Muscle Weakness: ICU-acquired weakness affects mobility and fall risk
Polypharmacy: Multiple medications increase fall risk through various mechanisms

Hack: The "CAM-ICU" (Confusion Assessment Method for ICU) provides reliable delirium screening. Positive screens mandate fall prevention protocols and investigation of reversible causes.

Prevention Strategies

Evidence-based interventions include:

Multifactorial Risk Assessment: Systematic evaluation of all contributing factors
Medication Optimization: Deprescribing unnecessary fall-risk medications
Physical Therapy: Balance training and strength exercises
Environmental Modification: Adequate lighting, non-slip surfaces, grab bars
Assistive Devices: Appropriate walker or cane prescription with training

Clinical Pearl: The "STEADI" (Stopping Elderly Accidents, Deaths, and Injuries) algorithm provides evidence-based framework for fall risk assessment and intervention in clinical practice.

Future Directions

Emerging technologies offer new approaches to fall prevention:

Wearable Sensors: Continuous monitoring of gait parameters and fall detection
Artificial Intelligence: Predictive models for fall risk assessment
Telemedicine: Remote monitoring and intervention delivery
Pharmacogenomics: Personalized medication selection based on genetic factors

Research priorities include developing better biomarkers for fall risk, understanding gene-environment interactions, and evaluating novel therapeutic interventions.

Conclusion

Unexplained falls in the elderly represent a complex syndrome requiring systematic neurological evaluation. Understanding the pathophysiology of parkinsonism, normal pressure hydrocephalus, cerebellar ataxia, sensory neuropathy, orthostatic hypotension, and frontal lobe disease enables targeted diagnostic approaches and evidence-based interventions. Critical care practitioners must recognize that falls often result from multiple interacting factors and that successful prevention requires comprehensive, multidisciplinary management.

The key to successful fall prevention lies in early recognition, systematic evaluation, and targeted intervention addressing all contributing factors. As our understanding of fall mechanisms continues to evolve, personalized approaches based on individual risk profiles and underlying pathophysiology will become increasingly important.

References

Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med. 1988;319(26):1701-1707.
Bloem BR, Hausdorff JM, Visser JE, Giladi N. Falls and freezing of gait in Parkinson's disease: a review of two interconnected, episodic phenomena. Mov Disord. 2004;19(8):871-884.
Pickering RM, Grimbergen YA, Rigney U, et al. A meta-analysis of six prospective studies of falling in Parkinson's disease. Mov Disord. 2007;22(13):1892-1900.
Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015;30(12):1591-1601.
Espay AJ, Da Prat GA, Dwivedi AK, et al. Deconstructing normal pressure hydrocephalus: Ventriculomegaly as early sign of neurodegeneration. Ann Neurol. 2017;82(4):503-513.
Krauss JK, Regel JP, Vach W, et al. Vascular risk factors and arteriosclerotic disease in idiopathic normal-pressure hydrocephalus of the elderly. Stroke. 1996;27(1):24-29.
Hashimoto M, Ishikawa M, Mori E, Kuwana N. Diagnosis of idiopathic normal pressure hydrocephalus is supported by MRI-based scheme: a prospective cohort study. Cerebrospinal Fluid Res. 2010;7:18.
Manto M, Bower JM, Conforto AB, et al. Consensus paper: roles of the cerebellum in motor control--the diversity of ideas on cerebellar involvement in movement. Cerebellum. 2012;11(2):457-487.
Klockgether T, Mariotti C, Paulson HL. Spinocerebellar ataxia. Nat Rev Dis Primers. 2019;5(1):24.
Vinik AI, Nevoret ML, Casellini C, Parson H. Diabetic neuropathy. Endocrinol Metab Clin North Am. 2013;42(4):747-787.
England JD, Gronseth GS, Franklin G, et al. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy. Neurology. 2009;72(2):177-184.
Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Auton Neurosci. 2011;161(1-2):46-48.
Ricci F, Fedorowski A, Radico F, et al. Cardiovascular morbidity and mortality related to orthostatic hypotension: a meta-analysis of prospective observational studies. Eur Heart J. 2015;36(25):1609-1617.
Yogev-Seligmann G, Hausdorff JM, Giladi N. The role of executive function and attention in gait. Mov Disord. 2008;23(3):329-342.
Montero-Odasso M, Verghese J, Beauchet O, Hausdorff JM. Gait and cognition: a complementary approach to understanding brain function and the risk of falling. J Am Geriatr Soc. 2012;60(11):2127-2136.

Author Information

Conflicts of Interest: None declared

Funding: None

Ethical Approval: Not applicable for this review article

Sunday, July 13, 2025